generics

Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Fri, 10/14/22 - 10:40 am
Novartis
Gilenya
generics
Supreme Court
MS
multiple sclerosis
FDA updates guidances to clarify new generic drug meeting requirements in GDUFA III
RAPS.org
Thu, 10/6/22 - 10:49 am
regulatory
FDA
generics
GDUFA
Generics, biosimilars saved the healthcare system $373B in 2021
Medical Marketing and Media
Sun, 10/2/22 - 07:43 pm
generics
biosimilars
A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
Wed, 09/28/22 - 11:38 am
generics
Europe
Teva Pharmaceutical
Sandoz
Merck pulls a patent win for diabetes franchise in West Virginia federal court
Endpoints
Thu, 09/22/22 - 11:12 pm
Merck
Januvia
Janumet
generics
legal
Viatris
Califf: FDA committed to boosting complex generic drug development
RAPS.org
Wed, 09/21/22 - 10:23 am
Robert Califf
FDA
generics
drug development
Over $50M in federal funds are going to Virginia’s pharma manufacturing sector
Endpoints
Tue, 09/6/22 - 05:09 pm
Virginia
federal government
generics
drug manufacturing
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Novartis
drug manufacturing
Sandoz
generics
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
spinoffs
Novartis
Sandoz
generics
Indivior fails to escape class action lawsuit in Suboxone case
Endpoints
Tue, 08/23/22 - 10:25 pm
Indivior
legal
Suboxone
generics
opioids
opioid addiction
GSK claps back at Teva in 'skinny' label case, arguing verdict doesn't threaten companies who act 'properly'
Fierce Pharma
Tue, 08/23/22 - 10:29 am
GSK
Teva Pharmaceutical
generics
legal
skinny labels
Endo loses Vasostrict patent battle as sales take a hit from generics
Endpoints
Sun, 08/21/22 - 09:43 pm
Endo International
Vasostrict
patents
generics
Eagle Pharmaceuticals
Expert: OGD on track to approve more generic drugs in FY2022
RAPS.org
Sun, 08/14/22 - 10:33 pm
FDA
generics
OGD
Bausch takes hit in Xifaxan patent feud, potentially paving the way for Norwich's IBS-D generic
Fierce Pharma
Mon, 08/1/22 - 10:33 am
Bausch Health
IBS-d
Xifaxan
legal
Norwich Pharmaceuticals
generics
Sanofi CEO Paul Hudson says his company is the Big Pharma 'least exposed' to generics this decade
Fierce Pharma
Thu, 07/28/22 - 12:23 pm
Sanofi
Paul Hudson
Pharma CEOs
generics
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
Wed, 07/13/22 - 10:03 am
China
drug pricing
price cuts
AstraZeneca
Pfizer
Novartis
generics
Dr. Reddy’s launches extended-release rival to $200M Pfizer drug
Fierce Pharma
Mon, 07/11/22 - 05:52 pm
Dr Reddy's
Pfizer
overactive bladder
Toviaz
generics
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Fri, 07/1/22 - 09:49 am
Novartis
spinoffs
generics
M&A
Sandoz
private equity
UCB lowers 2022 profit expectations amid Ukraine war, rising costs
Fierce Pharma
Mon, 06/27/22 - 10:09 am
UCB Pharma
Ukraine
Russia
generics
Teva, after Lupin deal, holds another Austedo generic challenger to a 2033 launch
Fierce Pharma
Sun, 06/12/22 - 08:19 pm
Teva Pharmaceutical
Austedo
generics
patents
tardive dyskinesia
Aurobindo

Pages